KDELR1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.086300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.738000E-01
Normal-vs-Stage2
9.274100E-02
Normal-vs-Stage3
5.490600E-01
Normal-vs-Stage4
9.828200E-02
Stage1-vs-Stage2
8.939800E-01
Stage1-vs-Stage3
5.681600E-01
Stage1-vs-Stage4
6.428000E-01
Stage2-vs-Stage3
4.669800E-01
Stage2-vs-Stage4
5.312400E-01
Stage3-vs-Stage4
3.964800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.073800E-02
Normal-vs-AfricanAmerican
2.481600E-01
Normal-vs-Asian
6.547900E-02
Caucasian-vs-AfricanAmerican
7.675600E-01
Caucasian-vs-Asian
2.284400E-01
AfricanAmerican-vs-Asian
3.403800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.792000E-02
Normal-vs-Female
8.338100E-02
Male-vs-Female
3.649200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.204800E-01
Normal-vs-Age(41-60Yrs)
1.840170E-02
Normal-vs-Age(61-80Yrs)
1.436590E-01
Normal-vs-Age(81-100Yrs)
4.923600E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.708600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.487600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.912200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.513000E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.078200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.418400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.476200E-01
Normal-vs-Daily Drinker
6.702100E-02
Normal-vs-Weekly Drinker
5.020300E-02
Normal-vs-Occasional Drinker
2.254200E-02
Normal-vs-Social Drinker
1.339560E-01
Non Drinker-vs-Daily Drinker
6.153900E-02
Non Drinker-vs-Weekly Drinker
1.593630E-01
Non Drinker-vs-Occasional Drinker
1.756070E-02
Non Drinker-vs-Social Drinker
2.059400E-01
Daily Drinker-vs-Weekly Drinker
7.227000E-01
Daily Drinker-vs-Occasional Drinker
6.340000E-01
Daily Drinker-vs-Social Drinker
7.316200E-01
Weekly Drinker-vs-Occasional Drinker
3.788000E-01
Weekly Drinker-vs-Social Drinker
9.821000E-01
Occasional Drinker-vs-Social Drinker
4.373600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.576600E-01
Normal-vs-Grade 2
6.213000E-01
Normal-vs-Grade 3
5.873800E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
8.736000E-01
Grade 1-vs-Grade 3
5.587600E-01
Grade 1-vs-Grade 4
3.576600E-01
Grade 2-vs-Grade 3
3.870800E-01
Grade 2-vs-Grade 4
6.213000E-01
Grade 3-vs-Grade 4
5.873800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.948600E-01
Normal-vs-NonDiabetic
3.620200E-02
Diabetic-vs-NonDiabetic
1.753810E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.952200E-02
Normal-vs-NoPancreatitis
7.130000E-02
Pancreatitis-vs-NoPancreatitis
5.996600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.589800E-02
Normal-vs-N1
1.084600E-01
N0-vs-N1
3.566600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.713930E-02
Normal-vs-TP53-NonMutant
3.334200E-01
TP53-Mutant-vs-TP53-NonMutant
4.565500E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
